MedPath

Alterations in F-18 fluorodeoxyglucose PET/MRI and O-15 water PET brain findings in patients with neurological symptoms after COVID-19 vaccination: A pilot study

Completed
Conditions
functional abnormalities in the brain of patients with neurological side effects following COVID-19 vaccination
Immunization stress-related responses, COVID-19, stress, O-15 water, PET/MRI, FDG
Registration Number
TCTR20210902006
Lead Sponsor
ational Cyclotron and PET Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
8
Inclusion Criteria

neurological symptoms after the first COVID-19 vaccination underwent CT, MRI, F-18 FDG PET/MRI and O-15 water PET of the brain. After 7 days, each patient underwent a follow-up F-18 FDG PET/MRI and O-15 water PET of the brain.

Exclusion Criteria

none

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Metabolic pattern 1st visit and 7 day after Quantitative and visual
Secondary Outcome Measures
NameTimeMethod
Perfusion abnormality 1st visit and 7 day after Quantitative and visual
© Copyright 2025. All Rights Reserved by MedPath